Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001079973-06-000134
Filing Date
2006-02-27
Accepted
2006-02-27 16:02:50
Documents
1
Period of Report
2006-02-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 10464
  Complete submission text file 0001079973-06-000134.txt   12353
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Issuer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2838 GARRETT DRIVE FORT COLLINS CO 80526
Business Address (970) 225-1355
Donnelly Richard G (Reporting) CIK: 0001316244 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50019 | Film No.: 06646686